17. Colorectal Cancer in Ulcerative Colitis: Surveillance

  1. John WD McDonald Professor of Medicine3,
  2. Andrew K Burroughs Professor of Hepatology Consultant Physician/Hepatologist4,
  3. Brian G Feagan Professor of Medicine3 and
  4. M Brian Fennerty Professor of Medicine5
  1. Paul Collins1,
  2. Bret A Lashner2 and
  3. Alastair JM Watson1

Published Online: 22 JUL 2010

DOI: 10.1002/9781444314403.ch17

Evidence-Based Gastroenterology and Hepatology, Third Edition

Evidence-Based Gastroenterology and Hepatology, Third Edition

How to Cite

Collins, P., Lashner, B. A. and Watson, A. J. (2010) Colorectal Cancer in Ulcerative Colitis: Surveillance, in Evidence-Based Gastroenterology and Hepatology, Third Edition (eds J. W. McDonald, A. K. Burroughs, B. G. Feagan and M. B. Fennerty), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314403.ch17

Editor Information

  1. 3

    Robarts Clinical Trials, Robarts Research Unit, University of Western Ontario, London, Ontario, Canada

  2. 4

    The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital, and University College London, London, UK

  3. 5

    Oregon Health and Science University, Division of Gastroenterology and Hepatology, Portland, Oregon, USA

Author Information

  1. 1

    School of Clinical Sciences, University of Liverpool, Liverpool, UK

  2. 2

    Center for Inflammatory Bowel Disease, Cleveland Clinic, Cleveland, USA

Publication History

  1. Published Online: 22 JUL 2010
  2. Published Print: 10 SEP 2010

ISBN Information

Print ISBN: 9781405181938

Online ISBN: 9781444314403

SEARCH

Keywords:

  • Epidemiological investigation;
  • Improving cancer surveillance programs in ulcerative colitis;
  • Colorectal cancer in ulcerative colitis: Surveillance;
  • number-needed-to-treat (NNT);
  • dysplasia-associated lesion or mass (DALM);
  • DNA fingerprinting or fluorescent in situ hybridization;
  • The natural history of the risk of cancer in IBD

Summary

This chapter contains sections titled:

  • Epidemiological investigation

  • Axioms

  • Questions

  • Chemoprevention

  • Improving cancer surveillance programs in ulcerative colitis

  • References